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Background Many patients and families are referred to our centre for the
screening after sudden cardiac death (SCD). Usual tests failed to unmask a
specific pathology in 60% of the families. Because of the potential of mental
stress to unmask ECG abnormalities, mental stress test (MST) was realized in
all patients since summer 2013.
Methods The protocol was defined before the beginning of the study and
usually consisted in mental arithmetic. Control group was defined by 30
healthy volunteers among hospital’s employees who accepted to undergo
MST. 12-lead ECG was realized at rest and at stress peak.
Results ECG from 57 patients (30 affected and 27 non affected family
members) coming from 4 different families were analyzed. 
Results were compared to 30 healthy volunteers. At least one SCD
occurred in each of the four families for a total of 6 SCD. Seven additional
patients experienced syncope probably related to arrhythmias (31.4% of symp-
tomatic patients. Transmission of the disease seems followed an autosomal
dominant pathway. QTc at rest was longer in affected family members
430±32ms vs non affected family members 402±23ms and healthy volunteers
396±23ms (p<0.001). During MST Δ QTc (msec) was 69±45ms vs 30±27ms
vs 32±20ms (<0.001). QTc prolongation was associated with T waves flat-
tening or double-hump morphology (13 vs 1 vs 3; p<0.001). No ventricular
arrhythmia was observed during MST. During exercise test there was no pro-
longation of the QTc interval in the three groups. Genetic analysis have been
performed in the probands in each family but remained negative whereas all
the genes involved in the LQTS have been tested.
Conclusion This is the first description of a new type of congenital LQTS
characterized by normal QTc at rest but prolongation of the QTc interval and
abnormal T waves during mental stress. This new form of LQTS seems
related to a severe arrhythmic prognosis and is not related to the gene defects
described in this pathology.
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Introduction Brugada syndrome (BS) is characterized by a typical ECG
pattern. To carrying out the diagnosis in patients without a spontaneous ECG
pattern, sodium channel blocker (SCB) is used. However, the value of this test
is not well known, particulary its sensibility because of a complex genetic
model do not allowing the use of any mutation as a gold standard. To clarify
the value of this test, we analyzed a database of 680 SCB performed in fami-
lies affected by the syndrome, considering the mandatory transmitters (MT) as
a true positive. 
Methods All patients who underwent a SCB and belonging to a family
with at least 2 subjects with the syndrome were included. The MT was defined
by an individual with at least one descendant in the first degree and an ascen-
dant with a BS or unexplained sudden cardiac arrest. All the ECG data at
baseline and at diagnosis was reviewed by two expert, blinded to the clinical
and genetical status. 
Results Of the 137 selected families, 85 MT were identified. Excluding
individuals who have not benefited from the SCB, sensitivity of test was cal-
culated at 91% (42/46). According to the molecule used, the sensitivity was
significantly better for ajmaline than flecainide with a sensitivity of 97% and
75% respectively (p =0.048). Among the 680 individuals who benefited a
SBC, the duration of the S wave in DII, DIII and V5 and the R wave in aVR
were significantly elongated at both baseline and diagnosis, in individuals with
a positive SBC. Complications occurred in 1.6% of patients (11/680)
including 4 required an electrical cardioversion. Risk factors present a compli-
cation was the youngest age and the occurrence of a complication with a
member of his family.
Conclusion This study demonstrates for the first time, the excellent sensi-
tivity of SCB in BS, particulary with the use of ajmaline. Complications are
rare and doesn’t appeared to be linked with QRS enlargement but with
familial history of ventricular arythmia during the test
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Purpose The cardiovascular mortality of the psychiatric patients is higher
than the general population. The antipsychotics and their propriety of prolon-
gation of the QT interval seems to be a possible track. We tried to analyze the
epidemiological, clinical, biological, therapeutic and especially electrocardio-
graphic (ECG) data in those patients, to determine the prevalence of the syn-
drome of prolongation of the QT interval and investigate its main risk factors.
Methods We conducted a cross-sectional study, at the university psychi-
atric center Ibn Rochd of Casablanca, in collaboration with the cardiology
department, over one year, concerning 134 patients receiving an antipsychotic
treatment, we realized12 derivations ECG, and assessed clinical, biological
and pharmacological data.
Results The mean age was 32, 48±10,9 year,82,8% men/17,2% women,
the first psychiatric disorder was the paranoid schizophrenia 56%, hyperka-
lemia was present in1 patient, hyermagnesaemia (1),calcemia was normal,
polytherapy has been found in the majority of cases(2.8±0.9), neuroleptics
were prescribed for all patients(45.5% for long term),in association with ben-
zodiazepines (25%) and anticholinergics (23%), antidepressant (21%) and
lithium (10%).The mean dose antipsychotic chlorpromazine equivalent (CPZ
eq) is 617.8±534, 3mg/d, 88% of patients are under moderate doses and only
6% receive very high doses >2000mg/d CPZ eq. the mean heart rate was
82.7±16.5 BPM, one patient had a bradycardia to 44 bpm. The mean QTc is
386.22±30,9ms, the prevalence of long QT syndrome (>440ms) in our series
is 4.5% so lower than the literature. The mean value of QTc increases with
age, and it is higher in female gender, the risk of QT prolongation is associ-
ated with multiple co-prescribed drugs, and gets higher with the number of
prescribed drugs and with strong dosage. The risk increases also at the begin-
ning of the treatment and in patients with long term treatment >6 months.
Conclusion However, despite the proven toxicity of these treatments, it
must be remembered that the QT prolongation does not necessarily induce a
negative risk-benefit balance. This is to be assessed on a case-by-case, and in
cooperation between psychiatrists, cardiologists, pharmacists, for a better
control of the risk of sudden cardiac death from a psychiatric medication
origin.
The author hereby declares no conflict of interest
January 14th, Thursday 2016
